News and Opinions  –  2021

ReAct input to the WHO Executive Board Session on Antimicrobial Resistance

Share the article

2021-01-28

Antimicrobial resistance was back on the agenda when the 148th WHO Executive Board which took place from January 18-26. A number of ReAct's nodes developed position documents for Member State delegates and the WHO to consider in response to the stock taking report produced by the WHO secretariat.

The input documents highlighted a number of key points including:

  • the urgent need for establishing global governance structures and the development of key performance indicators,
  • increased efforts for mobilize financial support for the implementation of National action plans,
  • initiatives to mobilize and engage youth on the issue of antimicrobial resistance,
  • renewed efforts to resolve the crisis in Research & Development of new antibiotics,

as well as a more active role of the WHO in generating actionable data on the global and national resistance situation through point prevalence studies.

Read more in the documents below

One of the key points in the ReAct Europe brief.

ReAct Europe

6 key points to consider – briefing to WHO Executive Board Session on AMR (PDF)